These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20415686)

  • 1. Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence.
    Fonseca VA; Handelsman Y; Staels B
    Diabetes Obes Metab; 2010 May; 12(5):384-92. PubMed ID: 20415686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus.
    Bays HE; Cohen DE
    Curr Med Res Opin; 2007 Jul; 23(7):1673-84. PubMed ID: 17588297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE; Goldberg RB; Truitt KE; Jones MR
    Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of colesevelam on lowering glycemia and lipids.
    Aggarwal S; Loomba RS; Arora RR
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus.
    Levy P; Jellinger PS
    Postgrad Med; 2010 May; 122(3Suppl):1-8. PubMed ID: 20581432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
    Staels B
    Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
    Ooi CP; Loke SC
    Diabet Med; 2014 Jan; 31(1):2-14. PubMed ID: 24024701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
    Rosenstock J; Rigby SP; Ford DM; Tao B; Chou HS
    Horm Metab Res; 2014 May; 46(5):348-53. PubMed ID: 24356792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus.
    Sonnett TE; Levien TL; Neumiller JJ; Gates BJ; Setter SM
    Clin Ther; 2009 Feb; 31(2):245-59. PubMed ID: 19302898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
    Elkeles RS
    Diabet Med; 2014 Jul; 31(7):880. PubMed ID: 24588426
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
    [No Abstract]   [Full Text] [Related]  

  • 20. Colesevelam for the management of type 2 diabetes.
    Marrs JC
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):187-94. PubMed ID: 19239397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.